Elicio Therapeutics Inc. (ELTX) Live Share Price, Invest From India

Elicio Therapeutics Inc. Stock Performance

as on April 23, 2026 at 3:11 am IST

Day's Low
Day's High
$12.00
Day's Price Range
$12.39
$12.09
0.74%
Downside
2.48%
Upside
52 Week's Low
52 Week's High
$4.70
52-Week Price Range
$14.93
$12.09
61.12%
Downside
23.49%
Upside

Elicio Therapeutics Inc. share price movements today

Previous Close: $12.18
Open: $12.18
Volume: 141.6K
Day's Low - High: $12.00 - $12.39
52 Week Low - High: $4.70 - $14.93

Elicio Therapeutics Inc. Historical Returns

1 Month Return: + 12.26 %
3 Month Return: + 52.06 %
1 Year Return: + 141.19 %
3 Year Return: 0 %
5 Year Return: 0 %

Elicio Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Elicio Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$224.4M

EPS (TTM)

-1.95

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-37.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-60013.19%

Elicio Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Elicio Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Elicio Therapeutics Inc.	BUY	$224.4M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.2B	123.87%	131.81	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.1B	102.14%	28.5	32.94%
BeiGene, Ltd.	NA	$36.5B	NA	128.25	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.2B	52.39%	18.05	31.41%

Stock Returns calculator for Elicio Therapeutics Inc. Stock including INR - Dollar returns

The Elicio Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Elicio Therapeutics Inc. investment value today

Current value as on today

₹2,63,563

Returns

₹1,63,563

(+163.56%)

Returns from Elicio Therapeutics Inc. Stock

₹1,39,406 (+139.41%)

Dollar Impact

₹24,157 (+24.16%)

Analyst Recommendation on Elicio Therapeutics Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Elicio Therapeutics Inc.. Average target price of $18.33

Elicio Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Elicio Therapeutics Inc..

What analysts predicted

34.04%UPSIDE

Target Price

$18.33

Current Price

$12.09

Analyzed by

8 Analysts

Target

$18.33

Elicio Therapeutics Inc. target price $18.33, a slight upside of 34.04% compared to current price of $12.09. According to 8 analysts rating.

Elicio Therapeutics Inc. Stock’s Investor Sentiment and Interest

Search interest for Elicio Therapeutics Inc. Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 23, 2026 to April 22, 2026

Change:-44% versus previous 30 day period

Elicio Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	1	-	-	-	-
Gross Profit	-	0	0	0	0	0	0	0	0	0
Operating Income	-10	-9	-10	-10	-10	-13	-10	-10	-8	-8
EBITDA	-10	-8	-11	-6	-18	-13	-10	-10	-9	-6
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-8	-11	-7	-18	-14	-11	-10	-10	-7
Income Tax Expense	0	0	0	-	-	0	-	-	-	-
Net Income	-10	-8	-11	-7	-18	-14	-11	-10	-10	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-1201.03%	0.00%	0.00%	0.00%	0.00%

Elicio Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2012	Dec 2013	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	7	6	4	1	2	28	-	-	-	-
Gross Profit	3	3	3	0	1	27	-1	-1	-1	-1
Operating Income	0	0	-14	-38	-55	-39	-23	-35	-44	-37
EBITDA	1	0	-14	-40	-70	-51	-23	-32	-50	-36
Interest Expense	0	0	-	-	8	0	3	1	0	1
Depreciation	-	-	-	0	0	0	0	1	1	1
Income Before Tax	1	1	-20	-40	-80	-54	-28	-35	-51	-39
Income Tax Expense	0	0	-	0	0	0	3	-	-	-
Net Income	0	0	-20	-40	-80	-26	-28	-35	-51	-39
Net Profit Margin	4.21%	9.61%	-497.02%	-2734.23%	-2781.49%	-93.25%	0.00%	0.00%	0.00%	0.00%

Elicio Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-8	-11	-7	-18	-14	-11	-10	-10	-7
Operating Cash Flow	-9	-12	-8	-7	-8	-10	-8	-11	-6
Investing Cash Flow	-	0	0	0	0	-	-	-	0
Financing Cash Flow	7	11	0	30	0	10	11	9	4
Change in Cash	-2	-1	-8	23	-8	0	3	-1	-2

Elicio Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2013	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	0	-20	-40	-80	-26	-28	-35	-51	-39
Operating Cash Flow	1	-8	-24	-22	-23	-22	-32	-37	-36
Investing Cash Flow	0	-	0	0	0	0	0	0	0
Financing Cash Flow	-1	31	4	52	19	21	38	42	36
Change in Cash	0	23	-19	29	-5	-1	5	5	0

Insights on Elicio Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 years, ELTX stock has moved up by 1456.9%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ELTX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ELTX has outperformed top 5 stocks with highest market-cap in its industry

About Elicio Therapeutics Inc.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.

Organisation	Elicio Therapeutics Inc.
Headquarters	451 D Street, Boston, MA, United States, 02210
Industry	Biotechnology
CEO	Mr. Robert T. Connelly
E-voting on shares	Click here to vote

Key Management of Elicio Therapeutics Inc.

Name	Title
Dr. Christopher M. Haqq M.D., Ph.D.	Executive VP, Head of Research & Development and Chief Medical Officer
Ms. Joy Seymour	VP & Head of Regulatory Affairs
Dr. Peter DeMuth Ph.D.	Chief Scientific Officer
Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.	Founder & Independent Director
Dr. Darrell J. Irvine Ph.D.	Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board
Dr. Preetam Shah M.B.A., Ph.D.	Chief Strategy & Financial Officer and Treasurer
Mr. Marc J. Wolfgang M.S.	Chief Technology Officer
Ms. Megan C. Filoon	General Counsel, Secretary & Compliance Officer
Ms. Esther Welkowsky	Senior Vice President of Clinical Development
Mr. Robert T. Connelly	CEO, President & Director

FAQs

What is Elicio Therapeutics Inc. share price today?

Elicio Therapeutics Inc. share price today is $12.09 as on April 22, 2026 at 9:41 pm IST. Elicio Therapeutics Inc. share today touched a day high of $12.39 and a low of $12.

What is the 52 week high and 52 week low for Elicio Therapeutics Inc. share?

Elicio Therapeutics Inc. share touched a 52 week high of $14.93 on March 2, 2026 and a 52 week low of $4.7 on April 29, 2025. Elicio Therapeutics Inc. stock price today i.e. April 22, 2026 at 9:41 pm IST is trending at $12.09,which is 19.02% down from its 52 week high and 157.23% up from its 52 week low.

What is Elicio Therapeutics Inc.'s market capitalisation today?

Elicio Therapeutics Inc. market capitalisation is $0.00T as on April 22, 2026 at 9:41 pm IST.

How to invest in Elicio Therapeutics Inc. Stock (ELTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Elicio Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Elicio Therapeutics Inc. Shares that will get you 0.1241 shares as per Elicio Therapeutics Inc. share price of $12.09 per share as on April 22, 2026 at 9:41 pm IST.

What is the minimum amount required to buy Elicio Therapeutics Inc. Stock (ELTX) from India?

Indian investors can start investing in Elicio Therapeutics Inc. (ELTX) shares with as little as ₹93.775 or $1 (as of April 22, 2026 at 9:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.75 in Elicio Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on April 22, 2026 at 9:42 pm IST). Based on Elicio Therapeutics Inc. share’s latest price of $12.09 as on April 22, 2026 at 9:41 pm IST, you will get 0.8271 shares of Elicio Therapeutics Inc.. Learn more about fractional shares .